Table 3.
Haemodynamics
| Variable | Placebo (n=11) | Drug (n=11) | p Value* |
|---|---|---|---|
| Heart rate, bpm | |||
| Predrug | 66±13 | 66±9 | 0.98 |
| Postdrug | 61±12 | 64±7 | 0.38 |
| Post-PCI | 70±19 | 71±7 | 0.82 |
| SBP, mm/Hg | |||
| Predrug | 126±22 | 121±32 | 0.67 |
| Postdrug | 123±22 | 121±27 | 0.83 |
| Post-PCI | 127±36 | 116±25 | 0.43 |
| DBP, mm/Hg | |||
| Predrug | 74±13 | 68±13 | 0.25 |
| Postdrug | 70±14 | 66±10 | 0.52 |
| Post-PCI | 71±20 | 64±12 | 0.30 |
| MAP, mm/Hg | |||
| Predrug | 96±16 | 90±18 | 0.42 |
| Postdrug | 91±17 | 89±14 | 0.82 |
| Post-PCI | 95±26 | 85±15 | 0.29 |
*p Values for pretreatment comparisons are provided for descriptive purposes. Data are expressed as mean±SD.
DBP, diastolic blood pressure; MAP, mean arterial pressure; PCI, percutaneous coronary intervention; SBP, systolic blood pressure.